ST elevation myocardial infarction analgesic therapy

Revision as of 22:46, 15 February 2009 by C Michael Gibson (talk | contribs)
Jump to navigation Jump to search
Myocardial infarction
ICD-10 I21-I22
ICD-9 410
DiseasesDB 8664
MedlinePlus 000195
eMedicine med/1567  emerg/327 ped/2520

WikiDoc Resources for ST elevation myocardial infarction analgesic therapy

Articles

Most recent articles on ST elevation myocardial infarction analgesic therapy

Most cited articles on ST elevation myocardial infarction analgesic therapy

Review articles on ST elevation myocardial infarction analgesic therapy

Articles on ST elevation myocardial infarction analgesic therapy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ST elevation myocardial infarction analgesic therapy

Images of ST elevation myocardial infarction analgesic therapy

Photos of ST elevation myocardial infarction analgesic therapy

Podcasts & MP3s on ST elevation myocardial infarction analgesic therapy

Videos on ST elevation myocardial infarction analgesic therapy

Evidence Based Medicine

Cochrane Collaboration on ST elevation myocardial infarction analgesic therapy

Bandolier on ST elevation myocardial infarction analgesic therapy

TRIP on ST elevation myocardial infarction analgesic therapy

Clinical Trials

Ongoing Trials on ST elevation myocardial infarction analgesic therapy at Clinical Trials.gov

Trial results on ST elevation myocardial infarction analgesic therapy

Clinical Trials on ST elevation myocardial infarction analgesic therapy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ST elevation myocardial infarction analgesic therapy

NICE Guidance on ST elevation myocardial infarction analgesic therapy

NHS PRODIGY Guidance

FDA on ST elevation myocardial infarction analgesic therapy

CDC on ST elevation myocardial infarction analgesic therapy

Books

Books on ST elevation myocardial infarction analgesic therapy

News

ST elevation myocardial infarction analgesic therapy in the news

Be alerted to news on ST elevation myocardial infarction analgesic therapy

News trends on ST elevation myocardial infarction analgesic therapy

Commentary

Blogs on ST elevation myocardial infarction analgesic therapy

Definitions

Definitions of ST elevation myocardial infarction analgesic therapy

Patient Resources / Community

Patient resources on ST elevation myocardial infarction analgesic therapy

Discussion groups on ST elevation myocardial infarction analgesic therapy

Patient Handouts on ST elevation myocardial infarction analgesic therapy

Directions to Hospitals Treating ST elevation myocardial infarction analgesic therapy

Risk calculators and risk factors for ST elevation myocardial infarction analgesic therapy

Healthcare Provider Resources

Symptoms of ST elevation myocardial infarction analgesic therapy

Causes & Risk Factors for ST elevation myocardial infarction analgesic therapy

Diagnostic studies for ST elevation myocardial infarction analgesic therapy

Treatment of ST elevation myocardial infarction analgesic therapy

Continuing Medical Education (CME)

CME Programs on ST elevation myocardial infarction analgesic therapy

International

ST elevation myocardial infarction analgesic therapy en Espanol

ST elevation myocardial infarction analgesic therapy en Francais

Business

ST elevation myocardial infarction analgesic therapy in the Marketplace

Patents on ST elevation myocardial infarction analgesic therapy

Experimental / Informatics

List of terms related to ST elevation myocardial infarction analgesic therapy

Cardiology Network

Discuss ST elevation myocardial infarction analgesic therapy further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Analgesia

Although, the recommendation for morphine induced pain relief has been reduced to a Class IIa recommendation for patient with unstable angina pectoris (UA) and Non ST Elevation Myocardial Infarction (NSTEMI), the use of opiate analgesics (e.g. morphine) remains a Class I recommendation for patients with STEMI.

In contrast to morphine and aspirin, cyclooxygenase-2 (COX-2) inhibitors and other non steroidal anti inflammatory drugs should be discontinued immediately in the setting of STEMI in so far as they inhibit aspirin and their association with an increased risk of cardiovascular events. [1]

Mechanism of Benefit

The hyperadrenergic state that accompanies vessel occlusion and the pain of vessel occlusion may benefit from management with analgesic agents. A hyperadrenergic state has been associated with a lower threshold for ventricular fibrillation. Morphine may act to reduce preload and afterload. Morphine may reduce metabolic needs and thereby reduce "demand ischemia". Morphine may also reduce the work of breathing, which again may reduce "demand ischemia".

Clinical Trial Data

While there is no large scale clinical trial data demonstrating an improvement in mortality or other hard endpoints associated with analgesic administration, analgesic agents do relieve anxiety and apprehension, both of which can heighten pain perception.

Dosing

Morphine sulfate (2 to 4 mg IV with increments of 2 to 8 mg IV repeated at 5- to 15-minute intervals)

Side Effects

Adverse effects can be seen in patients with morphine sensitivity.

  • Hypotension: Hypotension can be minimized by keeping the patient supine. If the systolic blood pressure drops below 100 mm Hg, then the lower extremities can be elevated.
  • Vagomimetic Effects such as Bradycardia: Intravenous atropine in doses of 0.5- to 1.5-mg doses intravenously may be helpful in reducing the excessive vagomimetic effects of morphine if significant bradycardia or hypotension occurs.
  • Respiratory Depression: Respiratory rate and depth should be monitored. The narcotic reversing agent naloxone, 0.1 to 0.2 mg intravenously, can be given initially if indicated and repeated after 15 minutes if necessary.
  • Nausea and Vomiting: May be treated with phenothiazines.

Guidelines (DO NOT EDIT)

Class I

1. Morphine sulfate (2 to 4 mg IV with increments of 2 to 8 mg IV repeated at 5- to 15-minute intervals) is the analgesic of choice for management of pain associated with STEMI. Class I (Level of Evidence: C)

2. Patients routinely taking NSAIDs (except for aspirin), both nonselective as well as COX-2 selective agents, before STEMI should have those agents discontinued at the time of presentation with STEMI because of the increased risk of mortality, reinfarction, hypertension, heart failure, and myocardial rupture associated with their use. Class I (Level of Evidence: C)[2]

References

  1. Gaziano JM, Gibson CM (2006). "Potential for drug-drug interactions in patients taking analgesics for mild-to-moderate pain and low-dose aspirin for cardioprotection". Am. J. Cardiol. 97 (9A): 23–9. doi:10.1016/j.amjcard.2006.02.020. PMID 16675319. Unknown parameter |month= ignored (help)
  2. Antman EM, Hand M, Armstrong PW; et al. (2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation. 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources